Risk of cancer associated with low-dose radiation exposure: comparison of results between the INWORKS nuclear workers study and the A-bomb survivors study.


Journal

Radiation and environmental biophysics
ISSN: 1432-2099
Titre abrégé: Radiat Environ Biophys
Pays: Germany
ID NLM: 0415677

Informations de publication

Date de publication:
03 2021
Historique:
received: 26 10 2020
accepted: 19 12 2020
pubmed: 23 1 2021
medline: 23 6 2021
entrez: 22 1 2021
Statut: ppublish

Résumé

The Life Span Study (LSS) of Japanese atomic bomb survivors has served as the primary basis for estimates of radiation-related disease risks that inform radiation protection standards. The long-term follow-up of radiation-monitored nuclear workers provides estimates of radiation-cancer associations that complement findings from the LSS. Here, a comparison of radiation-cancer mortality risk estimates derived from the LSS and INWORKS, a large international nuclear worker study, is presented. Restrictions were made, so that the two study populations were similar with respect to ages and periods of exposure, leading to selection of 45,625 A-bomb survivors and 259,350 nuclear workers. For solid cancer, excess relative rates (ERR) per gray (Gy) were 0.28 (90% CI 0.18; 0.38) in the LSS, and 0.29 (90% CI 0.07; 0.53) in INWORKS. A joint analysis of the data allowed for a formal assessment of heterogeneity of the ERR per Gy across the two studies (P = 0.909), with minimal evidence of curvature or of a modifying effect of attained age, age at exposure, or sex in either study. There was evidence in both cohorts of modification of the excess absolute risk (EAR) of solid cancer by attained age, with a trend of increasing EAR per Gy with attained age. For leukemia, under a simple linear model, the ERR per Gy was 2.75 (90% CI 1.73; 4.21) in the LSS and 3.15 (90% CI 1.12; 5.72) in INWORKS, with evidence of curvature in the association across the range of dose observed in the LSS but not in INWORKS; the EAR per Gy was 3.54 (90% CI 2.30; 5.05) in the LSS and 2.03 (90% CI 0.36; 4.07) in INWORKS. These findings from different study populations may help understanding of radiation risks, with INWORKS contributing information derived from cohorts of workers with protracted low dose-rate exposures.

Identifiants

pubmed: 33479781
doi: 10.1007/s00411-020-00890-7
pii: 10.1007/s00411-020-00890-7
pmc: PMC7902587
mid: NIHMS1666591
doi:

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

23-39

Subventions

Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Organisme : NIOSH CDC HHS
ID : R01 OH011409
Pays : United States

Références

Occup Environ Med. 2009 Dec;66(12):789-96
pubmed: 19570756
J Radiol Prot. 2017 Jun 26;37(2):422-433
pubmed: 28488593
J Natl Cancer Inst Monogr. 2020 Jul 1;2020(56):97-113
pubmed: 32657348
Br J Cancer. 2009 Jan 13;100(1):206-12
pubmed: 19127272
Ann ICRP. 2012 Oct-Dec;41(3-4):98-107
pubmed: 23089008
Environ Int. 2002 Mar;27(8):663-71
pubmed: 11934116
Radiat Res. 2007 Apr;167(4):380-95
pubmed: 17388692
Lancet Haematol. 2015 Jul;2(7):e276-81
pubmed: 26436129
Radiat Res. 2017 May;187(5):513-537
pubmed: 28319463
Int J Radiat Biol. 2018 Apr;94(4):307-314
pubmed: 29400635
Am J Epidemiol. 2009 Apr 15;169(8):969-76
pubmed: 19270049
Radiat Res. 2007 Jul;168(1):1-64
pubmed: 17722996
Radiat Res. 2012 Mar;177(3):229-43
pubmed: 22171960
Radiat Res. 2019 Aug;192(4):380-387
pubmed: 31390313
Ann ICRP. 2007;37(2-4):1-332
pubmed: 18082557
BMJ. 2015 Oct 20;351:h5359
pubmed: 26487649
Radiat Environ Biophys. 2015 Nov;54(4):379-401
pubmed: 26343037
Radiat Res. 2015 Jun;183(6):620-31
pubmed: 26010709
Epidemiology. 2018 Jan;29(1):31-40
pubmed: 28991003
Health Phys. 2017 Jan;112(1):56-97
pubmed: 27906788
Radiat Res. 2009 Sep;172(3):368-82
pubmed: 19708786
Radiat Res. 1993 Dec;136(3):408-21
pubmed: 8278584
Radiat Res. 2006 Jul;166(1 Pt 2):219-54
pubmed: 16808610
Int J Radiat Biol. 2017 Oct;93(10):1064-1078
pubmed: 28421857
Health Phys. 2019 Jan;116(1):96-99
pubmed: 30489371
Health Phys. 2005 Jul;89(1):3-32
pubmed: 15951689
Radiat Res. 2013 Mar;179(3):361-82
pubmed: 23398354
Radiat Res. 2015 Jun;183(6):632-42
pubmed: 26010707
Int J Epidemiol. 2016 Jun;45(3):693-9
pubmed: 26150557
BMJ. 2005 Jul 9;331(7508):77
pubmed: 15987704
Occup Environ Med. 2013 Sep;70(9):630-8
pubmed: 23716722
Health Phys. 2018 Jun;114(6):602-622
pubmed: 29697512
Br J Cancer. 2018 Aug;119(5):631-637
pubmed: 30108294
Radiat Res. 2017 Sep;188(3):276-290
pubmed: 28692406
Radiat Res. 1995 May;142(2):117-32
pubmed: 7724726
Radiat Prot Dosimetry. 2017 Apr 1;173(1-3):21-25
pubmed: 27885078
Radiat Res. 1994 Feb;137(2 Suppl):S68-97
pubmed: 8127953
Radiat Res. 1990 Sep;123(3):275-84
pubmed: 2217725
BMJ. 2015 Oct 20;351:h5405
pubmed: 26486561
Radiat Res. 1987 Jul;111(1):151-78
pubmed: 3446217
Radiat Res. 1965 May;25:25-52
pubmed: 14276324
J Radiat Res. 2018 Apr 1;59(suppl_2):ii1-ii10
pubmed: 29432579
Int J Cancer. 2017 Mar 15;140(6):1260-1269
pubmed: 27914102
Radiat Res. 2003 Oct;160(4):381-407
pubmed: 12968934
Ann ICRP. 2016 Jun;45(1_suppl):262-279
pubmed: 26960819
Radiat Environ Biophys. 2017 Nov;56(4):299-328
pubmed: 28939964
Ann ICRP. 2005;35(4):1-140
pubmed: 16782497

Auteurs

Klervi Leuraud (K)

Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Fontenay-aux-Roses, France. klervi.leuraud@irsn.fr.

David B Richardson (DB)

Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.

Elisabeth Cardis (E)

Center for Research in Environmental Epidemiology, Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Ciber Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Robert D Daniels (RD)

National Institute for Occupational Safety and Health (NIOSH), Cincinnati, OH, USA.

Michael Gillies (M)

Public Health England Centre for Radiation, Chemical and Environmental Hazards (PHE-CRCE), Chilton, UK.

Richard Haylock (R)

Public Health England Centre for Radiation, Chemical and Environmental Hazards (PHE-CRCE), Chilton, UK.

Monika Moissonnier (M)

International Agency for Research On Cancer (IARC), Lyon, France.

Mary K Schubauer-Berigan (MK)

International Agency for Research On Cancer (IARC), Lyon, France.

Isabelle Thierry-Chef (I)

Center for Research in Environmental Epidemiology, Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.
Ciber Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Ausrele Kesminiene (A)

International Agency for Research On Cancer (IARC), Lyon, France.

Dominique Laurier (D)

Institut de Radioprotection et de Sûreté Nucléaire (IRSN), Fontenay-aux-Roses, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH